Acyclonine MUM™

Acyclovir / Triamcinolone Acetonide / Dyclonine HCI / Dental Powder

3.0 Grams

Acyclonine MUM™, with its patented delivery process, aids in the management of, and for the temporary relief of, symptoms that may be associated with Acute and Chronic Oral Mucosal Ulcerations, Oral Mucositis, Aphthous Ulcers, and ulcerative lesions.
A 10% discount will be given to orders of 10 or more units.
Initial order of Acyclonine MUM requires a copy of doctors state medical license, NPI Identifier, and a signed Prescriber’s-Credentialing Statement. Within 72 hours of medical license validation you will receive a call or email to finalize your order. The credentialing validation process only needs to be completed for the initial order.

PROVIDERS:

When ordering Acyclonine MUM, you can rest assured that our contracted partner FDA Registered Outsourcing Facility will produce our patented formulation. It is designed and operated to meet cGMP (Current Good Manufacturing Practice) standards including the Drug Quality and Security ACT regulations. Furthermore, our Outsource Facility partner adheres to the guidance provided by under section 503B of The Drug Quality and Security Act. Our partner is regularly inspected by the State Boards of Pharmacy, DEA, and FDA to assure compliance. The key to providing safe compounded products resides in using the principles of cGMP. This allows us to maintain the highest degree of supply chain integrity and compliance with state and federal regulations.

Warnings

If irritation develops, this medicine should be discontinued. This medication contains a corticosteroid; monitor your patient for HPA axis suppression if prolonged therapy is needed. Do not use if your patient experiences severe or troublesome adverse reactions, becomes pregnant or intends to become pregnant, or breastfeeds.

Precautions

Do not prescribe this medication if your patient has any hypersensitivities to dyclonine, acyclovir, or triamcinolone. Do not use if the patient has an active fungal or bacterial infection of the mouth or throat. A reduced dosage of dyclonine may be required in elderly patients and children.

Possible Side Effects

As reported for the individual active ingredients per scientific literature. Burning; itching; irritation; dryness; erythema; pain; stinging; blistering or peeling not present prior to therapy; perioral dermatitis; allergic contact dermatitis; maceration of the oral mucosa; hives; aphthous ulcers; secondary infection; atrophy of the oral mucosa; HPA axis suppression with systemic absorption; cardiovascular events with high plasma levels of dyclonine hydrochloride upon excessive dosage or rapid absorption; myocardium depression; hypotension; hypertension; bradycardia; cardiac arrest; drowsiness; convulsions; apprehension; euphoria; confusion; tinnitus; double vision; vomiting; twitching; sensations of heat; respiratory depression; respiratory arrest; nervousness, with excessive dosing; dizziness; blurred vision; tremors; diarrhea; nausea; sore gums.

Directions For Use:

Keeping bottle upright rotate the arm to the required angle to deliver powder directly to the affected area. If needed use a mirror to insure the proper angle of the arm. Spray 1 or 2 sprays to the affected area 3 to 4 times per day or as directed by your oral care provider. 30 Day Supply.

Scroll to Top

Partner With Us

Join us on the ground floor of a transformative journey with RAM Pharmaceuticals.

As we lead the charge in developing groundbreaking treatments for Severe Oral Mucositis and dental pain management, this is your chance to invest in a company poised for exponential growth. With FDA-approved innovations and a commitment to enhancing patient comfort, RAM Pharmaceuticals is setting new standards in the pharmaceutical industry.

Don’t miss your opportunity to be a catalyst for change! Be the first to know by sharing your email address, and our team will keep you informed as soon as the investment opportunity goes live. Don’t miss out—act now!